José A. Pérez‐Molina

Author

Hospital Universitario Ramón y Cajal ORCID

Also Known As

A. R. Domínguez, Begoña Monge-Maillo, E Casas, Ferran Torres, J A Molina, J A Perez, J A Perez-Molina, J A Pérez Molina, J A Pérez-Molina, J A Pérez‐Molina

316

Publications

12K

Citations

H-Index

167

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal de Investigación Sanitaria Instituto Cajal Instituto de Salud Carlos III Hospital Universitario 12 De Octubre

About

José A. Pérez‐Molina is an author at Hospital Universitario Ramón y Cajal specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	58	3.1K
2	Public Health	19	24	863
3	Health Sciences	6	6	482
4	Social Sciences	3	3	285
5	Engineering	2	2	34

José A. Pérez‐Molina

111

Publications

Citations

H-Index

Page 1

	Year	Citations
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers Carlos A. Morillo, Hetty Waskin, Sergio Sosa‐Estáni, Journal of the American College of Cardiology Eliminating ParasitesParasitic DiseaseAntiparasitic AgentMedicineParasitic Protozoa	2017	309
Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment? José A. Pérez‐Molina, Mar�a Jos� S�inz-Artiga, Alicia Fraile, Movement Disorders Behavioral AddictionPsychopharmacologySocial SciencesDopaminergic ToneNeurology	2000	252
Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio Sergio Serrano‐Villar, Maria Jesús Pérez‐Elías, Fernando Dronda, PLoS ONE	2014	202
Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs Félix Javier Jiménez‐Jiménez, Alberto Nieto, José Montojo, Journal of Voice PhoniatricsHealth SciencesParkinson DiseaseAcoustic Voice AnalysisPathological Speech	1997	173
Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain. Rogelio López‐Vélez, José A. Pérez‐Molina, Antonio Guerrero, American Journal of Tropical Medicine and Hygiene Primary ImmunodeficiencyParasitic DiseaseTreatment And PreventionNeurovirologyImmunodeficiencies	1998	144
Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero, The Lancet Infectious Diseases Hiv/aids CounsellingTreatment And PreventionNeurovirologyHuman RetrovirusImmunology	2015	130
Short‐Course Therapy for Right‐Side Endocarditis Due to<i>Staphylococcus aureus</i>in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin Jesús Fortün, Enrique Navas, J Martínez-Beltrán, Clinical Infectious Diseases Randomized Clinical TrialAntimicrobial SusceptibilityHealth SciencesAntibioticsCloxacillin Group	2001	128
Old and new challenges in Chagas disease José A. Pérez‐Molina, Angela Martinez Perez, Francesca Norman, The Lancet Infectious Diseases Disease MechanismParasitic ProtozoaAfrican TrypanosomiasisPathogenesisGastroenterology	2015	109
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study Javier Martínez‐Sanz, Alfonso Muriel, Raquel Ron, Clinical Microbiology and Infection Long CovidMedicineMulticentre Cohort StudyCovid-19 PandemicClinical Epidemiology	2020	108
Imported Infectious Diseases in Mobile Populations, Spain Begoña Monge‐Maíllo, Beatriz C. Jiménez, José A. Pérez‐Molina, Emerging infectious diseases MalariaEpidemiological DynamicDisease OutbreakPathogen EpidemiologyHealth Screening	2009	105

Page 1